Camrelizumab Plus Apatinib Versus Chemotherapy for Initial Primary Unresectable Hepatic Carcinoma: a Randomized, Controlled, Single-Center, Phase II Study
Latest Information Update: 02 Dec 2020
At a glance
- Drugs Camrelizumab (Primary) ; Rivoceranib (Primary) ; Fluorouracil; Oxaliplatin
- Indications Carcinoma; Cholangiocarcinoma; Liver cancer
- Focus Therapeutic Use
- 02 Dec 2020 New trial record